Mobile vans deliver HIV prevention shots to unhoused angelenos

NCT ID NCT07467018

Recruiting now Prevention Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to prevent HIV by giving a long-acting injectable medication called lenacapavir through mobile health vans. It aims to reach 100 people in Los Angeles who are unhoused or unstably housed and face barriers to regular clinic visits. Participants receive the injection every 26 weeks, and researchers track how many start and stay on the prevention regimen over a year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

UCLA Health Homeless Healthcare Collaborative
RECRUITING

Santa Monica, California, 90404, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••